You've just added:

Home / News

News + Media

May 05, 2016

Nature Article on Philanthropy in Drug Development Features The Harrington Project for Discovery and Development

For the past decade, venture philanthropists have been working to propel promising therapies and vaccines into the clinic, with some success.Venture philanthropist Bill Gates looks on as a health worker vaccinates a child in GhanaIn December 2015, Facebook founder Mark Zuckerberg and his wife Priscilla Chan made a stunning... Continue Reading

May 02, 2016

Allinaire Therapeutics, a New Biotechnology Start-Up, Launches to Combat Lung Diseases

CLEVELAND AND INDIANAPOLIS – May 2, 2016 – BioMotiv, a drug development accelerator associated with the Harrington Project, and Indiana University Research and Technology Corp. announce the formation of a new biotechnology start-up, Allinaire Therapeutics. Allinaire Therapeutics aims to develop novel therapeutics for... Continue Reading

April 18, 2016

Arix Bioscience Has Made $25 Million Commitment to Leading Therapeutics Research Accelerator, BioMotiv

LONDON, APRIL 18, 2016: - Arix Bioscience Limited (Arix Bioscience), formerly Perceptive Bioscience Investments Limited, a global healthcare and life science company supporting medical innovation, announced today it has agreed to provide up to $25 million capital to BioMotiv LLC, a US-based therapeutic accelerator organization... Continue Reading

April 13, 2016

Charles River Laboratories and BioMotiv Enter Into Strategic Partnership

WILMINGTON, MA, April 13, 2016 – Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for Discovery & Development. Through this partnership, Charles River will... Continue Reading

March 15, 2016

Harrington Discovery Institute and The American Society for Clinical Investigation honor Jeffery M. Friedman, MD, PhD

CLEVELAND – The third annual Harrington Prize for Innovation in Medicine has been awarded to Jeffrey M. Friedman, MD, PhD, of The Rockefeller University, New York City, for his discovery of leptin and the leptin-mediated pathway that controls feeding behavior.The Harrington Prize for Innovation in Medicine, established in... Continue Reading

February 29, 2016

Harrington Scholar-Innovator Darren Carpizo Launches Z53 Therapeutics, a New Oncology Start-Up Combating Cancer-Associated Mutation

Formed by BioMotiv and Rutgers UniversityCLEVELAND AND NEW BRUNSWICK— FEBRUARY 29, 2016— BioMotiv, a drug development accelerator associated with The Harrington Project, and Rutgers, the State University of New Jersey, are announcing the formation of a new biotechnology startup, Z53 Therapeutics. Z53 Therapeutics aims to... Continue Reading

February 11, 2016

Cleveland Jewish News Profiles 'Genius' Dr. Jonathan Stamler, Harrington Discovery Institute Director

Dr. Jonathan Stamler, director of The Harrington Discovery Institute at University Hospitals in Cleveland, has earned a reputation as a “genius.”“Some people are geniuses,” his father‐in‐law Norman Wain said. “Geniuses have a capacity to work.”“He has this sort of infectious personality to want to drive... Continue Reading

January 13, 2016

Announcing our 2016 Harrington Scholar-Innovator Award Recipients

Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio has announced the 2016 recipients of Harrington Scholar-Innovator Awards. The awards support breakthrough work of physician-scientists whose discovery research shows promise of advancing the standard of care.The Harrington... Continue Reading